Create your account

Analyse episodes, create alerts, spot trends before they go mainstream

Already have an account? Sign in

People

Michael Osterholm

Mentioned in 4 analyzed podcast episodes across 4 shows

Director of the Center for Infectious Disease Research at the University of Minnesota who specializes in vaccine policy. He is frequently consulted as an expert on how regulatory changes—particularly modifications to vaccine approval rules—impact the pharmaceutical industry and public health outcomes. Podcasts feature his analysis on the consequences of loosening vaccine regulations, including the potential effects on companies' decisions to operate in the U.S. market.

Episode Appearances

PBS News Hour - Full Show

PBS News Hour - Full Show · Feb 18, 2026

February 17, 2026 - PBS News Hour full episode

Director of Center for Infectious Disease Research at University of Minnesota; expert on vaccine policy impacts

mRNA Vaccine Development and FDA Approval ProcessChildhood Vaccination Recommendations Policy ChangesTrump Administration Health Policy and Robert F. Kennedy Jr. Influence
View Analysis
Marketplace All-in-One

Marketplace All-in-One · Feb 17, 2026

Why would the Fed loosen mortgage regulations?

University of Minnesota expert; warns that changing vaccine approval rules drive companies away from U.S.

Federal Reserve Mortgage Regulation ReformBank Capital Requirements and Mortgage LendingNon-Bank Fintech Competition in Mortgage Market
View Analysis
Marketplace

Marketplace · Feb 17, 2026

Why would the Fed loosen mortgage regulations?

University of Minnesota expert warning that changing vaccine approval regulations drive companies away from U.S. market

Federal Reserve Mortgage Regulation ReformBank Capital Requirements and Mortgage LendingNon-Bank Mortgage Origination Market Share
View Analysis
Making Sense with Sam Harris

Making Sense with Sam Harris · Oct 3, 2025

#436 — A Crisis of Trust

50-year career in infectious disease epidemiology; advised multiple presidential administrations on pandemic and bioterrorism preparedness

Airborne transmission and aerosol science in respiratory virusesPandemic preparedness and biosecurity infrastructuremRNA vaccine technology development and deployment
View Analysis